Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colonic Neoplasms × relatlimab × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 7 Carcinoma, Non-Small-Cell Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Nasopharyngeal Carcinoma 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Locally Advanced Melanoma 1 Glioblastoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1

Interventions

Oxaliplatin 9 Bevacizumab 9 Capecitabine 7 Blood Specimen Collection 7 Folfox protocol 5 Fluorouracil 5 Cetuximab 5 trifluridine tipiracil drug combination 4 pembrolizumab 4 fludarabine 4 dostarlimab 4 Specimen Handling 4 Nivolumab 4 Leucovorin 4 Cyclophosphamide 4 XELOX 3 Irinotecan 3 IFL protocol 3 HMPL-013 3 Drug Therapy 3 Biopsy 3 toripalimab 2 tipiracil 2 regorafenib 2 pertuzumab 2 encorafenib 2 cemiplimab 2 atezolizumab 2 aldesleukin 2 Trifluridine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡